When the Chief Executive of a FTSE 100 private equity giant reaches into his own pocket to buy shares, the City usually stops talking and starts buying. Simon Borrows, the long-standing architect of 3i Group, recently dropped significant personal capital into the company he leads, signaling a defiant vote of confidence in a strategy that many critics find increasingly lopsided. This isn’t just a routine "skin in the game" maneuver. It is a calculated signal sent to a market that is starting to wonder if 3i is becoming a one-trick pony, overly dependent on a Dutch discount retailer while it hunts for a new crown jewel in the United States.
The move comes at a time when the private equity industry is facing its toughest environment since the 2008 crash. Higher interest rates have turned the cheap-debt taps off, making the traditional "buy, strip, and flip" model nearly impossible to execute profitably. Yet, 3i has managed to remain a darling of the London Stock Exchange. Most of that success is credited to Action, the non-food discount chain that has expanded across Europe with predatory efficiency. But Borrows knows that European retail has its limits. To justify its premium valuation, 3i must prove it can replicate its mid-market success on American soil, a graveyard for many ambitious European firms that failed to grasp the sheer scale and volatility of the U.S. consumer market. Meanwhile, you can read other stories here: Starmer’s Blame Game and the Myth of Imported Energy Poverty.
The Action Trap and the Diversification Dilemma
To understand why Borrows is doubling down now, you have to look at the massive shadow Action casts over the rest of the 3i portfolio. Action currently accounts for a staggering portion of 3i’s Net Asset Value (NAV). While the retailer continues to post double-digit growth, this concentration creates a "key man" risk at a corporate scale. If Action hits a wall—whether through market saturation or a shift in European consumer spending—3i’s share price would likely crater.
Borrows is an old hand at this. He knows that the current valuation of 3i reflects the brilliance of the past decade, but the market is a forward-looking machine. The investor appetite for 3i isn’t just about milk runs in the Netherlands; it’s about whether 3i can find the "next Action" in the healthcare, industrial technology, or specialized consumer sectors of North America. The U.S. is the only market with the depth to absorb the kind of capital 3i needs to deploy to move the needle. To explore the full picture, check out the detailed analysis by Harvard Business Review.
Buying shares personally is a classic "lead from the front" tactic. It tells institutional investors that the boss isn't worried about the concentration risk. He is telling them that the U.S. expansion isn't a gamble; it's an inevitable evolution. However, the reality on the ground is more complex. U.S. valuations remain stubbornly high despite rate hikes, and the competition for mid-market assets is fierce, with every major American PE house sitting on mountains of "dry powder."
Cracking the American Mid Market
The 3i strategy has always been about the mid-market—companies that are too big for a local bank but too small for the global titans like Blackstone or KKR. In Europe, 3i owns this space. In the U.S., they are just another foreign fund with a British accent. To win, they have to apply the same operational rigor they used with Action: focusing on high volume, low complexity, and relentless cost control.
The U.S. push focuses on sectors that are relatively "recession-proof." Think specialized medical components, automated warehouse solutions, and essential infrastructure services. These aren't flashy "unicorn" tech companies. They are the plumbing of the modern economy. By investing in these areas, Borrows is trying to balance the portfolio’s volatility. If the U.S. consumer slows down, the industrial and healthcare assets provide a floor for the earnings.
But the execution is where most European firms stumble. The American labor market is more fluid, the regulatory environment is a patchwork of state-level headaches, and the sheer geography makes logistics a nightmare compared to the compact markets of the Eurozone. 3i isn't just buying companies; they are buying the expertise to navigate these regional nuances. This requires a cultural shift within the firm, moving away from a London-centric decision-making process to a more decentralized, boots-on-the-ground American operation.
The Interest Rate Reality Check
For years, private equity thrived on a simple formula: borrow cheap, improve operations slightly, and sell when multiples expanded. That world is dead. With the "higher for longer" interest rate environment, 3i has to prove it can generate returns through genuine organic growth and margin improvement, rather than just financial engineering.
The Borrows share purchase is a statement that 3i’s balance sheet is strong enough to weather these rates. Unlike many of its peers, 3i maintains a relatively conservative debt profile at the holding company level. This allows them to be hunters when others are forced to be sellers. When a competitor's portfolio company breaches a debt covenant, 3i can step in with cash.
This opportunistic approach is exactly why the U.S. ambitions are so critical. The American market is currently seeing a "shakeout" of weaker players. Firms that over-leveraged in 2021 are now struggling to refinance. For a well-capitalized veteran like Borrows, this is the perfect time to go shopping. He isn't buying at the peak; he’s buying when the fear is palpable.
Behind the Curtain of Director Deals
Why do we care if a CEO buys shares? In the world of high finance, these are "conviction signals." A CEO has more information than any analyst or journalist. They see the monthly management accounts of every portfolio company. They know which deals are in the pipeline and which ones are falling apart. When a CEO buys with their own money—not through a granted option or a bonus scheme, but by actually executing a trade—it suggests they believe the current share price doesn't reflect the true value of the pipeline.
In Borrows' case, this is also about legacy. Having led 3i through a period of incredible transformation, he is likely looking at his final act. He wants to leave 3i as a diversified global powerhouse, not just the company that got lucky with a Dutch retailer. The U.S. expansion is the final piece of that puzzle.
There is, of course, the counter-argument. Critics suggest that 3i is simply running out of ideas in Europe. The European economy is sluggish, burdened by aging demographics and heavy regulation. By comparison, the U.S. remains the engine of global growth. If you aren't winning in America, you aren't winning.
The Risk of Overextending
Despite the optimism, the path is littered with hazards. The U.S. market has a way of humbling even the most disciplined investors. The "Action" model works because of Europe's unique urban density and specific consumer habits. Replicating that in the sprawling suburbs of the American Midwest is a different beast entirely.
Furthermore, the "3i discount" is a real phenomenon. For years, the market has applied a discount to 3i’s share price because it is a listed private equity firm, which some investors find less transparent than traditional asset managers. Borrows has spent a decade fighting this discount. His recent share purchase is another attempt to close that gap, forcing the market to recognize the inherent value of the underlying assets.
Investors should watch the next three quarters closely. The key metrics won't just be the total return, but the "non-Action" earnings growth. If the U.S. acquisitions start contributing meaningful EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), the market will finally stop viewing 3i as a one-asset wonder. If those acquisitions stall, Borrows’ personal investment will look less like a masterstroke and more like a desperate attempt to shore up confidence.
Beyond the Balance Sheet
This isn't just about numbers; it's about the philosophy of capital. Borrows represents the "old school" of private equity—patient, disciplined, and operationally focused. This stands in stark contrast to the "growth at all costs" mentality that led to the collapse of firms like WeWork or the struggles of SoftBank’s Vision Fund.
3i’s approach in the U.S. will likely be boring. It will involve buying companies that make valves for oil rigs, or software for dental offices, or logistics systems for cold storage. These are not companies that make headlines, but they are companies that make money. In an era of volatility, "boring" is becoming the most attractive word in an investor's vocabulary.
The CEO’s move is a gamble on the stability of the American middle-market consumer and the resilience of industrial supply chains. It is a bet that the U.S. will continue to be the safest place for large-scale capital deployment, despite the political noise and the shifting interest rate landscape.
The Bottom Line for Investors
If you are holding 3i shares, the Borrows deal is a green light. It confirms that the leadership is fully aligned with the aggressive expansion into North America. However, do not expect overnight miracles. The U.S. pivot is a long-term play that will take years to fully mature.
The real test will be 3i’s ability to find value in a market where everyone is looking for the same thing. They cannot afford to overpay just to "get a deal done." Borrows' history suggests he won't. He has a reputation for walking away from the table if the math doesn't work. His recent share purchase suggests that, for the first time in a long time, he likes what he sees on the price tags in the American shop window.
Watch the debt levels of the new U.S. acquisitions. If 3i can keep them lean while pushing for market share, they will prove the skeptics wrong. If they get caught in a bidding war for mediocre assets, the "Action" profits will quickly be erased. The City is watching, the Americans are waiting, and Simon Borrows has just placed his biggest bet yet.
